Modulation of reperfusion injury after single lung transplantation by pentoxifylline, inositol polyanions, and sin-1

J Thorac Cardiovasc Surg. 1999 Mar;117(3):556-64. doi: 10.1016/s0022-5223(99)70335-1.

Abstract

Objective: Previous studies have suggested reductions in lung reperfusion injury with pentoxifylline, inositol polyanions, and the nitric oxide donor, SIN-1, but these agents have never been directly compared to ascertain which is superior. We investigated these agents in a porcine model of left single lung transplantation.

Methods: Donor lungs were preserved with modified Euro-Collins solution for a mean ischemic time of 18.4 hours. Neutrophil trapping in the graft, pulmonary vascular resistance, free radical release (measured by malonaldehyde levels) and gas exchange were assessed over a 12-hour period. All groups were reperfused at an initial pulmonary artery pressure of 20 mm Hg. Group A (n = 5) was a control group with no interventions added; group B was reperfused with the addition of intravenous inositol polyanions (0.02 mg/kg/h), and group C was reperfused with intravenous SIN-1 (0.02 mg/kg/h). Group D was reperfused with the addition of intravenous pentoxifylline (2 mg/kg/h).

Results: Neutrophil sequestration was observed within 10 minutes of reperfusion in group A. This was attenuated significantly by interventions in groups B, C, and D. In group D, malonaldehyde levels were significantly lower than in other groups and was associated with superior oxygenation. Pulmonary vascular resistance was reduced in groups B, C, and D compared with group A.

Conclusions: Pentoxifylline, when administered only to recipient animals was superior to the other interventions studied. Inositol polyanions are promising as a possible therapeutic intervention but were not as effective as the other agents studied.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Platelets / pathology
  • Female
  • Free Radical Scavengers / administration & dosage
  • Free Radical Scavengers / pharmacology
  • Lung / blood supply*
  • Lung / metabolism
  • Lung / pathology
  • Lung Transplantation*
  • Malondialdehyde / analysis
  • Molsidomine / administration & dosage
  • Molsidomine / analogs & derivatives*
  • Molsidomine / pharmacology
  • Neutrophils / pathology
  • Nitric Oxide Donors / administration & dosage
  • Nitric Oxide Donors / pharmacology
  • Pentoxifylline / administration & dosage*
  • Pentoxifylline / pharmacology
  • Phytic Acid / administration & dosage*
  • Phytic Acid / pharmacology
  • Pulmonary Circulation
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Reperfusion Injury / physiopathology
  • Reperfusion Injury / therapy*
  • Swine
  • Vascular Resistance

Substances

  • Free Radical Scavengers
  • Nitric Oxide Donors
  • Malondialdehyde
  • linsidomine
  • Phytic Acid
  • Molsidomine
  • Pentoxifylline